Niacinamide for Skin: Helpful or Overhyped?
WhatEvidence.Health claim check
Niacinamide for skin: helpful or overhyped?
Niacinamide is a real skincare ingredient with useful human evidence. The hype starts when it is sold as a one-step cure for acne, melasma, rosacea, wrinkles, and “barrier repair.”
Most supported uses: barrier support, oiliness, uneven tone, and modest texture changes. Treating rosacea itself is not established.
Topical niacinamide, also called nicotinamide, has promising human evidence as a support ingredient for skin barrier strength, oiliness, uneven pigmentation, and modest signs of photoaging. It is not a prescription-strength substitute for acne, melasma, or rosacea treatment, and higher percentages are not automatically better.
The claim
“Topical niacinamide improves acne, oiliness, dark spots, the skin barrier, rosacea-prone skin, and signs of aging.”
This claim is partly true, but it bundles several different skin problems together. The evidence is strongest when the claim is narrowed to supporting the skin barrier, reducing oiliness, helping uneven tone fade gradually, and modestly improving texture or fine lines.
“Topical” means applied to the skin. This article is about leave-on creams, gels, moisturizers, and serums, not oral niacinamide tablets.
Barrier support and water-loss reduction
Oiliness, acne support, uneven tone
Fine lines, texture, blotchiness
Rosacea claims need softer wording
What is niacinamide?
Niacinamide is the amide form of vitamin B3. In skincare studies, it is usually called niacinamide or nicotinamide.
It is not the same as niacin, also called nicotinic acid. Niacin is more associated with flushing, while niacinamide generally does not cause the same classic niacin flush.
Niacinamide is best framed as a support ingredient. It can help a routine work better, but it should not be sold as a stand-alone medical treatment for acne, melasma, eczema, or rosacea.
What the best evidence says
Press the arrow for more details.
Skin barrier and hydration
This is one of the most defensible uses.
A small left-right clinical study in 28 people with atopic dermatitis found that 2% nicotinamide cream reduced transepidermal water loss, which means water escaping through the skin, while white petrolatum did not significantly reduce that measure. Both treatments improved hydration, but nicotinamide improved hydration more than petrolatum in that study.10
Mechanistic work also supports this direction. A British Journal of Dermatology study reported that nicotinamide increased ceramide and other stratum corneum lipids, which are skin-barrier fats, and improved the permeability barrier.11 A 2023 randomized controlled study of niacinamide-containing body emollients in mild atopic dermatitis also reported improvements in symptoms, quality of life, and skin-barrier function.12
Oiliness and acne-prone skin
Niacinamide looks useful, but it is not a guideline-leading acne treatment.
In a clinical trial of 2% niacinamide, 100 Japanese subjects used either a niacinamide moisturizer or placebo for 4 weeks, and another 30 Caucasian subjects completed a randomized split-face study for 6 weeks. Sebum excretion rate fell significantly at 2 and 4 weeks in the Japanese study, while casual sebum levels fell at 6 weeks in the Caucasian study.1
Two acne trials compared 4% nicotinamide with 1% clindamycin. In one older double-blind randomized trial, 76 patients used 4% nicotinamide gel or 1% clindamycin gel twice daily for 8 weeks; improvement was similar, and papules or pustules fell by 60% with nicotinamide versus 43% with clindamycin, a difference that was not statistically significant.3 In a later randomized double-blind trial with 80 patients, acne grade improved similarly over 8 weeks in the nicotinamide and clindamycin groups, with no major side effects reported.2
That sounds encouraging, but there is a ceiling on the claim. The 2024 American Academy of Dermatology acne guideline gives strong recommendations to benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline, and conditional recommendations to topical clascoterone, salicylic acid, and azelaic acid. Niacinamide is not a headline first-line therapy in that guideline.4
Uneven pigmentation and melasma
Niacinamide can help pigmentation, but it works gradually and should be paired with sunscreen.
A mechanistic and clinical study found that niacinamide did not block tyrosinase directly, which is a key pigment enzyme. Instead, it inhibited melanosome transfer by 35% to 68% in a cell model and significantly reduced hyperpigmentation with increased skin lightness after 4 weeks in human clinical testing.5
In melasma, a small left-right randomized double-blind trial assigned 27 patients to 4% niacinamide on one side of the face and 4% hydroquinone on the other side for 8 weeks. Good-to-excellent improvement occurred in 44% of niacinamide-treated sides versus 55% of hydroquinone-treated sides.6
A 10-week randomized double-blind vehicle-controlled trial in women aged 40 to 60 tested moisturizers with 4% niacinamide plus 2% N-acetyl glucosamine. The active regimen was significantly more effective than vehicle for several measures of facial hyperpigmentation.7 N-acetyl glucosamine is a different ingredient, so that study supports the combination, not niacinamide alone.
Photoaging, texture, and fine lines
The effect is real enough to mention, but modest.
A 12-week split-face, left-right randomized clinical study of 5% niacinamide in aging facial skin reported improvement in fine lines, wrinkles, red blotchiness, hyperpigmented spots, yellowing, and elasticity compared with control.8 Another randomized split-face study in 30 Japanese women found that a cosmetic containing 4% niacinamide improved eye-area wrinkles over 8 weeks compared with a control cosmetic.9
The plain-English version: niacinamide can help skin look a little smoother and more even with regular use. It should not be described as a retinoid replacement or a major wrinkle treatment.
Rosacea-prone skin
Use the gentle-routine claim, not the disease-treatment claim.
A randomized, investigator-blind, controlled observational study in 50 subjects with rosacea found that a niacinamide-containing facial moisturizer improved barrier function and hydration, with improvement in signs and symptoms of rosacea over 4 weeks.13
That does not prove niacinamide treats rosacea in the same way as prescription rosacea medicines. The National Rosacea Society emphasizes moisturizer as a key part of rosacea care because rosacea often involves a defective moisture barrier and higher transepidermal water loss.14
Key studies
| Source | What to keep in mind |
|---|---|
Draelos 20061 | Human, controlled, practical cosmetic outcome. Short follow-up and different results by population. Takeaway: Promising for oiliness. |
Khodaeiani 20132 | Head-to-head acne trial, adequate N. Short follow-up and active comparator rather than placebo. Takeaway: Promising as acne support, not first-line proof. |
Shalita 19953 | Useful comparator trial. Older study, supported in part by industry, and short endpoint. Takeaway: Supports non-antibiotic adjunct framing. |
Liu 2020 Cochrane review15 | High-level evidence review. Niacinamide was only one ingredient group inside a broader review. Takeaway: Downgrades acne certainty. |
Hakozaki 20025 | Strong mechanism plus human signal. Some results are indirect and cosmetic-measure based. Takeaway: Promising for uneven tone. |
Navarrete-Solís 20116 | Direct melasma comparison. Small sample and short follow-up. Takeaway: Useful, not hydroquinone-equivalent proof. |
Bissett 20048 | Controlled facial study. Cosmetic endpoints and company-affiliated authors. Takeaway: Promising but modest for photoaging. |
Soma 200510 | Direct barrier measures. Small N and specific atopic dry-skin population. Takeaway: Good support for barrier wording. |
CIR safety assessment16 | Broad safety assessment. Ingredient safety does not prove every finished product will be tolerated. Takeaway: Generally well tolerated, not irritation-free. |
Are results consistent?
The evidence mostly points in the same direction: niacinamide can support the barrier, reduce some oiliness, help pigmentation measures, and modestly improve visible signs of aging.
The confidence is not equally strong across every claim. Barrier and oil-control claims have practical human data. Pigment claims have mechanism plus human studies. Acne has encouraging comparisons, but guideline-level acne evidence still favors other standard treatments.415
Many studies are short, often 4 to 12 weeks. Several are small, product-formula based, or industry-linked. There is no single large, independent body of trials proving that niacinamide is a major stand-alone treatment for every marketed use.
What this means for you
For most people, the most evidence-aligned choice is a simple leave-on product with about 2% to 5% niacinamide. That is the range most often reflected in the clinical evidence for oiliness, acne support, pigment support, photoaging, and barrier claims.1268
More is not automatically better. A 10% serum may suit some people, but the published clinical evidence does not clearly show that 10% beats 2% to 5% for the main consumer outcomes.
For acne, niacinamide can sit beside evidence-based acne care, but it should not replace benzoyl peroxide, retinoids, azelaic acid, or dermatologist-guided therapy when those are needed.4
For melasma or dark patches, sunscreen is not optional. Niacinamide may help uneven tone fade gradually, but pigment often relapses if ultraviolet and visible light exposure are not managed.
Safety note
Topical niacinamide is generally well tolerated. The Cosmetic Ingredient Review safety assessment reported no stinging sensation at concentrations up to 10%, no irritation in use tests up to 5%, and no irritation in a 21-day cumulative irritation test up to 5%.16
That does not mean every product is gentle for every person. Finished products can contain acids, retinoids, fragrances, preservatives, or high active loads that irritate sensitive skin.
You have rosacea, eczema, very reactive skin, active dermatitis, a damaged skin barrier, pregnancy or breastfeeding questions, or a prescribed acne or pigment routine. In those cases, review the full routine with a clinician rather than judging niacinamide in isolation.
Stop and reassess if a product causes persistent burning, swelling, worsening rash, or eye-area irritation.
What we still do not know
We still need larger, independent trials comparing different niacinamide strengths, such as 2%, 5%, and 10%, in the same population. We also need longer follow-up to know how well benefits persist with long-term use.
For acne, studies should compare niacinamide directly with modern first-line routines, not only older antibiotic comparators. For rosacea, trials need to measure core rosacea outcomes such as persistent redness, inflammatory bumps, burning, and flushing, not just moisturizer-related comfort.
For pigment, future studies should separate niacinamide-alone effects from multi-ingredient formulas that also contain sunscreen, N-acetyl glucosamine, tranexamic acid, vitamin C derivatives, or exfoliating acids.
WEH rating and why
PromisingThe overall claim earns a Promising rating.
There are multiple human clinical studies, including randomized and double-blind trials, and the results generally point toward benefit for barrier function, oiliness, pigmentation, and modest visible aging signs. The rating is capped because many studies are small or short, several use cosmetic endpoints, some are industry-linked, and rosacea-specific disease-treatment evidence is thin.
Frequently asked questions
It can help acne-prone skin, especially oiliness and inflammation, but it is best seen as an adjunct. Current acne guidelines still prioritize proven acne medicines such as benzoyl peroxide, topical retinoids, topical antibiotics, azelaic acid, and salicylic acid.4
Most clinical evidence clusters around 2% to 5% leave-on products. Higher-strength products may be fine for some people, but higher percentage does not automatically mean better results.
It can help uneven pigmentation gradually. The best evidence suggests it affects melanosome transfer, which is part of how pigment gets distributed into surface skin cells.5
Sources
- Draelos ZD, Matsubara A, Smiles K. The effect of 2% niacinamide on facial sebum production. Journal of Cosmetic and Laser Therapy. 2006. Clinical trial. PMID: 16766489. DOI: 10.1080/14764170600717704.
- Khodaeiani E, Fouladi RF, Amirnia M, Saeidi M, Karimi ER. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. International Journal of Dermatology. 2013. Randomized controlled trial. PMID: 23786503. DOI: 10.1111/ijd.12002.
- Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. International Journal of Dermatology. 1995. Randomized active-control trial. PMID: 7657446. DOI: 10.1111/j.1365-4362.1995.tb04449.x.
- Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2024. Clinical practice guideline. PMID: 38300170. AAD summary: updated acne guideline summary.
- Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. British Journal of Dermatology. 2002. Mechanistic and clinical study. PMID: 12100180.
- Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatology Research and Practice. 2011. Randomized trial. PMID: 21822427.
- Kimball AB, Kaczvinsky JR, Li J, et al. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine. British Journal of Dermatology. 2010. Randomized double-blind vehicle-controlled trial. PMID: 19845667. DOI: 10.1111/j.1365-2133.2009.09477.x.
- Bissett DL, Miyamoto K, Sun P, Li J, Berge CA. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. International Journal of Cosmetic Science. 2004. Split-face randomized clinical study. PMID: 18492135. DOI: 10.1111/j.1467-2494.2004.00228.x.
- Kawada A, Konishi N, Oiso N, et al. Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide. Journal of Dermatology. 2008. Randomized placebo-controlled split-face study. PMID: 19017042.
- Soma Y, Kashima M, Imaizumi A, Takahama H, Kawakami T, Mizoguchi M. Moisturizing effects of topical nicotinamide on atopic dry skin. International Journal of Dermatology. 2005. Left-right comparison study. PMID: 15807725.
- Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S. Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. British Journal of Dermatology. 2000. Mechanistic and human barrier study. PMID: 10971324. DOI: 10.1046/j.1365-2133.2000.03705.x.
- Zhu JR, et al. A single-center, randomized, controlled study on the efficacy of niacinamide-containing body emollients combined with cleansing gel in the treatment of mild atopic dermatitis. Skin Research and Technology. 2023. Randomized controlled study. PMID: 37753690.
- Draelos ZD. Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea. Cutis. 2005. Randomized investigator-blind controlled observational study. PMID: 16209160.
- National Rosacea Society. Moisturizer for Rosacea. Patient education guidance. Source page.
- Liu H, Yu H, Xia J, et al. Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid for acne. Cochrane Database of Systematic Reviews. 2020. Systematic review. PMID: 32356369.
- Cosmetic Ingredient Review Expert Panel. Final report of the safety assessment of niacinamide and niacin. International Journal of Toxicology. 2005. Safety assessment. PMID: 16596767.
